Cargando…
New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections
Ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol belong to a novel generation of antibiotics that correspond with the β-lactam family. It is necessary to having new options in treating infections caused by Gram-negative, non-fermenting multidrug-resistant bacilli due to the significant...
Autores principales: | Chumbita, Mariana, Monzo-Gallo, Patricia, Lopera-Mármol, Carlos, Aiello, Tommaso Francesco, Puerta-Alcalde, Pedro, Garcia-Vidal, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717454/ https://www.ncbi.nlm.nih.gov/pubmed/36285859 http://dx.doi.org/10.37201/req/s03.12.2022 |
Ejemplares similares
-
Controversies in the management of ESBL-producing Enterabacterales. Clinical Implications
por: Maseda, Emilio, et al.
Publicado: (2022) -
Treatment of infections caused by carbapenemase-producing Enterobacterales
por: Íñigo, Melania, et al.
Publicado: (2022) -
Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria
por: Silva, José Tiago, et al.
Publicado: (2021) -
Ceftolozane-tazobactam: When, how and why using it?
por: López, Inmaculada, et al.
Publicado: (2021) -
Ceftobiprole: a clinical view
por: Pérez-Crespo, Pedro María Martínez, et al.
Publicado: (2021)